Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Ultrasonographic and MRI characterisation of the palindromic phase of rheumatoid arthritis.

Bugatti S, Caporali R, Manzo A, Sakellariou G, Rossi S, Montecucco C.

Ann Rheum Dis. 2012 Apr;71(4):625-6. doi: 10.1136/annrheumdis-2011-200077. Epub 2011 Oct 28. No abstract available.

PMID:
22039169
2.

The presence of anti-cyclic citrullinated peptide antibody is associated with magnetic resonance imaging detection of bone marrow oedema in early stage rheumatoid arthritis.

Tamai M, Kawakami A, Uetani M, Takao S, Tanaka F, Nakamura H, Iwanaga N, Izumi Y, Arima K, Aratake K, Kamachi M, Huang M, Origuchi T, Ida H, Aoyagi K, Eguchi K.

Ann Rheum Dis. 2006 Jan;65(1):133-4. No abstract available.

3.

Clinical value of second- and third-generation assays of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis.

Kitahara K, Takagi K, Kusunoki Y, Nishio S, Nozaki T, Inomata H, Takei M, Sawada S, Kawai S.

Ann Rheum Dis. 2008 Jul;67(7):1059-60. doi: 10.1136/ard.2007.082826. No abstract available.

PMID:
18556455
4.

Biological significance of anti-cyclic citrullinated peptide antibody in rheumatoid arthritis.

Roubenoff R, Beckman E, Weinblatt M, Shadick N, Gregersen PK.

Ann Intern Med. 2008 Mar 4;148(5):403; author reply 403-4. No abstract available.

PMID:
18316760
5.

Biological significance of anti-cyclic citrullinated peptide antibody in rheumatoid arthritis.

Arkfeld DG.

Ann Intern Med. 2008 Mar 4;148(5):403; author reply 403-4. No abstract available.

PMID:
18316759
6.

Diagnostic value of anti-cyclic citrullinated peptide antibodies to detect rheumatoid arthritis in patients with Sjögren's syndrome.

van Noord C, Hooijkaas H, Dufour-van den Goorbergh BC, van Hagen PM, van Daele PL, van de Merwe JP.

Ann Rheum Dis. 2005 Jan;64(1):160-2. No abstract available.

7.

Anti-cyclic citrullinated peptide antibodies in advanced rheumatoid arthritis.

Pinheiro GC, Scheinberg MA, Aparecida da Silva M, Maciel S.

Ann Intern Med. 2003 Aug 5;139(3):234-5. No abstract available.

PMID:
12899598
8.

Anti-cyclic citrullinated peptide in preclinical rheumatoid arthritis. Food for thought.

Ménard HA.

J Rheumatol. 2009 Apr;36(4):663-4. doi: 10.3899/jrheum.090184. No abstract available.

PMID:
19342718
9.

[Early prediction of joint destruction in rheumatoid arthritis].

Eguchi K.

Clin Calcium. 2007 Apr;17(4):517-25. Review. Japanese.

PMID:
17404480
10.

Anti-cyclic citrullinated peptide antibodies in the diagnosis of rheumatoid arthritis: bayes clears the haze.

Finckh A, Liang MH.

Ann Intern Med. 2007 Jun 5;146(11):816-7. No abstract available.

PMID:
17548414
11.

Anti-cyclic citrullinated peptide antibody in rheumatic diseases other than rheumatoid arthritis.

Matsui T, Shimada K, Tohma S.

Clin Rheumatol. 2006 Jul;25(4):610-1. Epub 2005 Nov 10. No abstract available.

PMID:
16283420
12.

[Trends in therapeutic guidelines for rheumatoid arthritis].

Miyasaka N.

Nihon Naika Gakkai Zasshi. 2008 Oct 10;97(10):2387-92. Review. Japanese. No abstract available.

PMID:
19149033
13.

[Anti-cyclic citrullinated peptide antibody as a serological marker for the diagnosis of rheumatoid arthritis].

Suzuki K.

Nihon Rinsho. 2005 Jan;63 Suppl 1:341-3. Review. Japanese. No abstract available.

PMID:
15799374
14.
15.

Determination of anti-CCP antibodies in patients with suspected rheumatoid arthritis: does it help to predict the diagnosis before referral to a rheumatologist?

Gao IK, Haas-Wöhrle A, Mueller KG, Lorenz HM, Fiehn C.

Ann Rheum Dis. 2005 Oct;64(10):1516-7. No abstract available.

16.

Likelihood ratios as a function of antibody concentration for anti-cyclic citrullinated peptide antibodies and rheumatoid factor.

Bossuyt X, Coenen D, Fieuws S, Verschueren P, Westhovens R, Blanckaert N.

Ann Rheum Dis. 2009 Feb;68(2):287-9. doi: 10.1136/ard.2007.085597. No abstract available.

PMID:
19139208
17.

[Anti-cyclic citrullinated peptide (CCP) antibodies].

Mimori T.

Nihon Rinsho. 2010 Jun;68 Suppl 6:491-4. Japanese. No abstract available.

PMID:
20942111
18.

Classification criteria for rheumatoid arthritis--time to abandon rheumatoid factor?

Symmons DP.

Rheumatology (Oxford). 2007 May;46(5):725-6. Epub 2007 Jan 10. No abstract available.

PMID:
17215261
19.

[Clinical significance of anti-CCP antibody in diagnosis of collagen diseases].

Mimori T.

Nihon Naika Gakkai Zasshi. 2007 Oct 10;96(10):2132-7. Review. Japanese. No abstract available.

PMID:
18044146
20.

IgM-rheumatoid factor and anti-cyclic citrullinated peptide decrease by 50% during intensive treatment in early rheumatoid arthritis.

van Tuyl LH, Lems WF, Kerstens PJ, Voskuyl AE, Dijkmans BA, Boers M.

Ann Rheum Dis. 2009 Oct;68(10):1652-3. doi: 10.1136/ard.2008.103184. No abstract available.

PMID:
19748920

Supplemental Content

Support Center